314 related articles for article (PubMed ID: 15788477)
1. Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy.
Chen JK; Chen J; Neilson EG; Harris RC
J Am Soc Nephrol; 2005 May; 16(5):1384-91. PubMed ID: 15788477
[TBL] [Abstract][Full Text] [Related]
2. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
[TBL] [Abstract][Full Text] [Related]
4. S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy.
Chen JK; Chen J; Thomas G; Kozma SC; Harris RC
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F585-93. PubMed ID: 19474189
[TBL] [Abstract][Full Text] [Related]
5. Alterations in mammalian target of rapamycin signaling pathways after traumatic brain injury.
Chen S; Atkins CM; Liu CL; Alonso OF; Dietrich WD; Hu BR
J Cereb Blood Flow Metab; 2007 May; 27(5):939-49. PubMed ID: 16955078
[TBL] [Abstract][Full Text] [Related]
6. The mTOR signaling pathway mediates control of ribosomal protein mRNA translation in rat liver.
Reiter AK; Anthony TG; Anthony JC; Jefferson LS; Kimball SR
Int J Biochem Cell Biol; 2004 Nov; 36(11):2169-79. PubMed ID: 15313464
[TBL] [Abstract][Full Text] [Related]
7. Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli.
Eley HL; Russell ST; Baxter JH; Mukerji P; Tisdale MJ
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E923-31. PubMed ID: 17609254
[TBL] [Abstract][Full Text] [Related]
8. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
Fang CX; Yang X; Sreejayan N; Ren J
Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
[TBL] [Abstract][Full Text] [Related]
9. Raptor-rictor axis in TGFbeta-induced protein synthesis.
Das F; Ghosh-Choudhury N; Mahimainathan L; Venkatesan B; Feliers D; Riley DJ; Kasinath BS; Choudhury GG
Cell Signal; 2008 Feb; 20(2):409-23. PubMed ID: 18068336
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice.
Sakaguchi M; Isono M; Isshiki K; Sugimoto T; Koya D; Kashiwagi A
Biochem Biophys Res Commun; 2006 Feb; 340(1):296-301. PubMed ID: 16364254
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the phosphorylation and integrity of protein synthesis initiation factor eIF4GI and the translational repressor 4E-BP1 by p53.
Constantinou C; Clemens MJ
Oncogene; 2005 Jul; 24(30):4839-50. PubMed ID: 15897901
[TBL] [Abstract][Full Text] [Related]
12. Rheb activation of mTOR and S6K1 signaling.
Hanrahan J; Blenis J
Methods Enzymol; 2006; 407():542-55. PubMed ID: 16757352
[TBL] [Abstract][Full Text] [Related]
13. Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy.
Chen J; Chen JK; Neilson EG; Harris RC
J Am Soc Nephrol; 2006 Jun; 17(6):1615-23. PubMed ID: 16641152
[TBL] [Abstract][Full Text] [Related]
14. Clofibrate treatment promotes branched-chain amino acid catabolism and decreases the phosphorylation state of mTOR, eIF4E-BP1, and S6K1 in rat liver.
Ishiguro H; Katano Y; Nakano I; Ishigami M; Hayashi K; Honda T; Goto H; Bajotto G; Maeda K; Shimomura Y
Life Sci; 2006 Jul; 79(8):737-43. PubMed ID: 16616211
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of ribosomal protein S6 mediates compensatory renal hypertrophy.
Xu J; Chen J; Dong Z; Meyuhas O; Chen JK
Kidney Int; 2015 Mar; 87(3):543-56. PubMed ID: 25229342
[TBL] [Abstract][Full Text] [Related]
16. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2.
Le Bacquer O; Petroulakis E; Paglialunga S; Poulin F; Richard D; Cianflone K; Sonenberg N
J Clin Invest; 2007 Feb; 117(2):387-96. PubMed ID: 17273556
[TBL] [Abstract][Full Text] [Related]
17. Meal feeding enhances formation of eIF4F in skeletal muscle: role of increased eIF4E availability and eIF4G phosphorylation.
Vary TC; Lynch CJ
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E631-42. PubMed ID: 16263769
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced hypomyelination in the developing brain is mammalian target of rapamycin-4E-binding protein-1 signaling dependent.
Bilali F; Kumar P; Feerick J; Berezin S; Farahani R
Neuroreport; 2008 Apr; 19(6):635-9. PubMed ID: 18382277
[TBL] [Abstract][Full Text] [Related]
19. Mechanism by which mammalian target of rapamycin inhibitors sensitize multiple myeloma cells to dexamethasone-induced apoptosis.
Yan H; Frost P; Shi Y; Hoang B; Sharma S; Fisher M; Gera J; Lichtenstein A
Cancer Res; 2006 Feb; 66(4):2305-13. PubMed ID: 16489035
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis.
Gao XM; Wong G; Wang B; Kiriazis H; Moore XL; Su YD; Dart A; Du XJ
J Hypertens; 2006 Aug; 24(8):1663-70. PubMed ID: 16877971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
